CitraFlow™ 46.7% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 46.7% trisodium citrate solution, specifically formulated for the locking and maintenance of vascular access devices such as central venous catheters. This non-antibiotic, citrate-based lock solution provides effective antimicrobial and anticoagulant protection, helping to prevent catheter occlusion and reduce infection risk.
Manufactured under strict quality and sterility standards in Canada, CitraFlow™ 46.7% SF syringes are ready-to-use, eliminating the need for on-site compounding or dilution. Each syringe is precision-filled and designed with a smooth plunger action and leak-resistant barrel to ensure consistent, controlled delivery.
The 46.7% citrate concentration provides reliable catheter patency without the bleeding risks associated with heparin-based locks. CitraFlow™ SF is free of preservatives and latex, making it suitable for a wide range of patients, including those with heparin sensitivities or allergies.
Ideal for hospitals, dialysis centers, infusion clinics, and long-term care facilities, CitraFlow™ SF Prefilled Syringes support safe, efficient, and standardized vascular access maintenance protocols.
CitraFlow™ 46.7% SF prefilled syringes are filled with an anticoagulant and antimicrobial 46.7% sodium citrate solution. CitraFlow™ 46.7% SF is a proven alternative to heparin to lock Vascular Access Devices. It avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.
